Gene Therapy

  • 8 Gene Therapy conferences you should attend in 2022

    8 Gene Therapy conferences you should attend in 2022

    With the first AAV-based gene therapies approved, and new gene editing strategies emerging, it’s important to stay on top of the latest topics in this therapeutic area. Here are 8 gene therapy...

    Read

  • [New] Prometheus Panta with SLS

    Build effective AAV vectors for gene therapy with
    high-quality stability profiling data

    Learn more
  • Ways light scattering technologies help you if you’re in gene therapy

    Ways light scattering technologies help you if you’re in gene therapy

    Read
  • ×

    Sign up to receive
    the latest gene therapy content, updates,
    and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • Four technologies to profile your AAVs

    Four technologies to profile your AAVs

    Read
  • Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Read
  • NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    SOUTH SAN FRANCISCO, Calif Feb 16 2022 — NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument...

    Read

  • Trying to develop safe and effective gene therapies?

    Biophysical methods can help.

    Find out how
  • Overcome bottlenecks in viral vector manufacturing25:08

    Overcome bottlenecks in viral vector manufacturing

    The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer that provides better long-term stability for AAVs is a crucial step in the process of developi

    Watch
  • How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods21:48

    How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

    Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addres

    Watch
  • The importance of molecular interactions and stability in Gene Therapy46:44

    The importance of molecular interactions and stability in Gene Therapy

    New advances in gene therapy have triggered a resurgence of interest in the field. Though gene therapy offers exciting potential for the treatment of both monogenic disorders as well as more genetical

    Watch
  • Solutions for gene therapy using a deeper analytical characterization of AAV vector development18:38

    Solutions for gene therapy using a deeper analytical characterization of AAV vector development

    Gene therapy—a type of DNA-based medicine that utilizes a virus to insert a healthy gene into cells to replace a mutated, disease-causing variant has emerged as one of the most promising medical treat

    Watch
  • Methods Matter: Standard production platforms for recombinant AAV produce chemically and functionally distinct vectors

    Methods Matter: Standard production platforms for recombinant AAV produce chemically and functionally distinct vectors

    Read
  • Quantitation of trace levels of DNA released from disrupted Adeno-associated virus gene therapy vectors

    Quantitation of trace levels of DNA released from disrupted Adeno-associated virus gene therapy vectors

    Read
  • Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy38:40

    Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy

    Gene therapy promises to treat and potentially cure a disease by correcting its underlying genetic cause. While gene therapies that utilize AAV vectors have shown encouraging results —including a few

    Watch
  • Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing

    Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing

    Read
  • Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids

    Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids

    Read
  • Intrinsic differential scanning fluorimetry for fast and easy identification of Adeno-Associated Virus serotypes

    Intrinsic differential scanning fluorimetry for fast and easy identification of Adeno-Associated Virus serotypes

    Read
  • Humanized Selective CD19CAR-T Cells Treatment Shows Efficacy in B-ALL Patients Who Relapsed after Receiving Murine-Based CD19CAR-T Therapies

    Humanized Selective CD19CAR-T Cells Treatment Shows Efficacy in B-ALL Patients Who Relapsed after Receiving Murine-Based CD19CAR-T Therapies

    Read
  • Spatial screening of hemagglutinin on Influenza A Virus particles: Sialyl-LacNAc displays on DNA and PEG scaffolds reveal requirements

    Spatial screening of hemagglutinin on Influenza A Virus particles: Sialyl-LacNAc displays on DNA and PEG scaffolds reveal requirements

    Read
  • loading
    Loading more...